Oct-2021 Assessment and Management of CV risk for Prostate Cancer Patients
Speakers:
Dr Patrick Davey – Consultant Cardiologist at Northampton General Hospital and University of Oxford, UK
Professor Thomas Keane – Professor and Chairman of the Department of Urology at the Medical University of South Carolina in Charleston, USA
In this session, organised by National Cancer Research Institute and funded by Ferring Pharmaceuticals, speakers will discuss cardiovascular prevalence and risk in prostate cancer patients. The session will also explore how to identify patients at high risk of future cardiovascular events and how to manage these patients through lifestyle modifications, pharmacological intervention, and optimisation of treatment modality to improve outcomes in clinical practice.
